Cerus Corporation (CERS) Financials

CERS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 222.9 million 154.6 million
Dec. 31, 2025 221.9 million 156.9 million
Sept. 30, 2025 215.2 million 153.0 million
June 30, 2025 213.1 million 156.9 million

CERS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.3 million 4.9 million
Dec. 31, 2025 4.9 million 10.6 million
Sept. 30, 2025 94000 5.6 million
June 30, 2025 -2.9 million 5.7 million

CERS Net Income

No data available :(

CERS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 80.4 million 32.4 million 9.4 million
Dec. 31, 2025 82.9 million 40.5 million 10.2 million
Sept. 30, 2025 78.5 million 48.7 million 10.7 million
June 30, 2025 78.0 million 56.8 million 14.0 million

CERS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 194.1 million
Dec. 31, 2025 192.1 million
Sept. 30, 2025 191.8 million
June 30, 2025 191.3 million

CERS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 233000 14.5 million 19.9 million -
Dec. 31, 2025 1.3 million 16.4 million 20.8 million -
Sept. 30, 2025 1.8 million 15.8 million 18.6 million -
June 30, 2025 477000 18.9 million 21.2 million -

CERS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 59.9 million 25.8 million
Dec. 31, 2025 57.8 million 28.0 million
Sept. 30, 2025 52.7 million 24.6 million
June 30, 2025 52.4 million 23.5 million

CERS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CERS

Price: $2.93

52 week price:
1.15
3.28

Earnings Per Share: -0.05 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 1.8 million

Ebitda: -11.8 million

Market Capitalization: 633.2 million

Links: